PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,558,000 | -77.2% | 50,000 | -66.7% | 0.02% | -79.5% |
| Q4 2017 | $6,848,000 | -10.0% | 150,000 | -26.0% | 0.12% | +7.0% |
| Q3 2017 | $7,611,000 | -17.8% | 202,700 | +4.4% | 0.11% | -17.4% |
| Q2 2017 | $9,257,000 | +153.8% | 194,082 | +142.6% | 0.14% | +160.4% |
| Q1 2017 | $3,648,000 | +90.8% | 80,000 | +43.2% | 0.05% | +76.7% |
| Q3 2016 | $1,912,000 | -21.1% | 55,872 | -5.3% | 0.03% | -21.1% |
| Q3 2015 | $2,424,000 | – | 58,991 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |